IMS Health study finds adherence boost among Medisafe users

WASHINGTON — Medication management platform Medisafe recently released data from an IMS Health study examining Medisafe’s impact on medication adherence that was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting here. 

 

The study looked at Medisafe users taking medication to manage cholesterol and hypertension and found respective 19.5% and 8.4% increases in adherence after sixth months compared to non-users. 

 

“This study revealed the promise of mHealth platforms such as Medisafe to increase medication adherence, which has a proven direct link to improved health outcomes, lower hospitalization rates and decreased medical costs,”Medisafe EVP Jon Michaeli said. “Medisafe's holistic approach of using scheduled reminders, a social support system, biofeedback, and individually personalized tools and resources, help patients sustain high levels of engagement for extended periods of time, which is critically important for chronic disease such as high cholesterol and high blood pressure.”

 

Medication non-adherence has been estimated to cost the U.S. up to $300 billion annually in avoidable health care costs, and the study concludes that broader use of mobile technology to support adherence could improve control of chronic diseases and lower costs. The full presentation from the ISPOR meeting can be found here,